Translation and Validation of the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA) to the Brazilian Context: An Instrument Focusing on Arrhythmia Symptoms
Table 1
Clinical characteristics of the participants (n = 140).
Variables
N
%
LVEF
Type of cardiac arrhythmia
Atrial fibrillation
71
50.71
Atrial flutter
19
13.57
Atrial tachycardia
2
1.43
Paroxysmal supraventricular tachycardia
7
5.00
Wolff–Parkinson–White
14
10.00
AV nodal re-entry
16
11.43
Ventricular tachycardia
1
0.71
Ventricular extrasystoles
6
4.29
Nonsustained ventricular tachycardia
4
2.86
Treatment
Medication
132
94.29
Catheter ablation
17
12.14
DC electrical cardioversion
5
3.57
Hospitalisation
78
55.71
Associated cardiovascular disease
87
62.14
Antiarrhythmic medication
122
87.14
Class I
10
7.14
Class I
91
65.00
Class III
18
12.86
Class IV
3
2.14
Oral anticoagulant
77
55.00
NYHA functional class
I
96
68.57
62 (SD 9.91)
II
43
30.71
55 (SD 13.15)
III
1
0.71
60 (SD 0)
Cardiovascular diseases
Hypertension
69
49.29
Cardiac valve replacement
16
11.43
Dyslipidaemia
16
11.43
Chagas disease
10
7.14
Dilated cardiomyopathy
2
1.43
Diabetes mellitus
32
22.86
Other clinical characteristics and comorbidity
Hypothyroidism
18
12.86
Systemic lupus erythematosus
3
2.14
LVEF = left ventricular ejection fraction. Participants could choose more than one answer option.
